pTVG-AR
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for pTVG-AR, covering 2026-01-28 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer [Phase 1, Phase 2]